Chirlaque María-Dolores, Uhry Zoé, Salmerón Diego, Sánchez-Zapata María-Isabel, Zannoni Gian Franco, Navarro Carmen
aDepartment of Epidemiology, Murcia Health Council, IMIB-Arrixaca bDepartment of Health and Social Sciences, Universidad de Murcia cDepartment of Gynaecology, St Lucía University Hospital, Cartagena, Murcia dBiomedical Research Networking Center Consortium Epidemiology and Public Health (CIBERESP), Spain eDepartment of Biostatistics, University Hospital of Lyon fUniversity of Lyon, Lyon gDepartment of Non-communicable Diseases and Injuries, French Institute for Public Health Surveillance (Invs), Saint-Maurice hCNRS, UMR5558, Biometry and Evolutionary Biology Laboratory (LBBE), BioMaths-Health Department iUniversity of Lyon 1, Villeurbanne, France jDepartment of Human Pathology, Catholic University of the Sacred Heart, Rome, Italy.
Eur J Cancer Prev. 2017 Jan;26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study:S107-S113. doi: 10.1097/CEJ.0000000000000302.
European Latin countries have some similarities in their health systems. It is thus interesting to look at their differences in cancer survival (here, ovarian cancer) through monitoring of specific indicators of quality care. The aim of this SUDCAN collaborative study was to compare the trends in 1 and 5-year net survival from ovarian cancer and the trends in the excess mortality rates between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland). The data were extracted from the EUROCARE-5 database. First, the net survival was studied over the 2000-2004 period using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland, and from 2000 to 2004 in Belgium and Portugal. The analyses were carried out using a flexible excess rate modelling. Over the period 2000-2004, there were slight differences in the 5-year age-standardized net survivals from ovarian cancer; they ranged from 36% in Spain to 42% in Belgium. Net survival was much higher in young than in old age groups, but this difference was more marked in Spain and less marked in France. Between 1992 and 2004, the net survival increased in all countries, mainly in young and middle-aged women. However, the differences in 5-year net survival between these countries were larger in 2004 than in 1992. Slight differences were observed in survival from ovarian cancer between the six European Latin countries. A considerable improvement in survival was observed in all countries, especially in young and middle-aged women. This study highlights the need for further monitoring of ovarian cancer outcomes.
欧洲拉丁国家的卫生系统存在一些相似之处。因此,通过监测优质护理的特定指标来研究它们在癌症生存率(此处为卵巢癌)方面的差异很有意思。这项SUDCAN合作研究的目的是比较六个欧洲拉丁国家(比利时、法国、意大利、葡萄牙、西班牙和瑞士)卵巢癌1年和5年净生存率的趋势以及超额死亡率的趋势。数据取自EUROCARE - 5数据库。首先,使用波哈尔 - 佩尔梅估计量研究了2000 - 2004年期间的净生存率。对于趋势分析,研究时间段因国家而异。法国、意大利、西班牙和瑞士的结果报告时间为1992年至2004年,比利时和葡萄牙为2000年至2004年。分析采用灵活的超额率建模方法。在2000 - 2004年期间,卵巢癌5年年龄标准化净生存率存在细微差异;范围从西班牙的36%到比利时的42%。年轻年龄组的净生存率远高于老年年龄组,但这种差异在西班牙更为明显,在法国则不太明显。1992年至2004年期间,所有国家的净生存率都有所提高,主要是年轻和中年女性。然而,2004年这些国家之间5年净生存率的差异比1992年更大。六个欧洲拉丁国家在卵巢癌生存率方面存在细微差异。所有国家的生存率都有显著提高,尤其是年轻和中年女性。这项研究强调了进一步监测卵巢癌结果的必要性。